Zaid Al-Aifari

Tech Investment / Real Estate

📍 Austria🔄 Updated September 2026💼 14 investments📅 6 years investing🗓 Last invested May 2024
VC🌍 Austria
14
Total investments
3
Early stage
8
Mid stage
1
Late stage
6y
Years active

Portfolio

14 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
May 2024
We believe that buying, selling, or investing in real estate seriously matters at any point in life. In this sense, we strive to provide the greatest opportunities possible to real estate professionals, who are present at each of these stages. To accomplish our vision we dedicated ourselves to bringing all of the world’s fragmented real estate data together in one place, enriching it with advanced analytics technologies to serve with the simplicity of our products.
Angel Investor
Apr 2024
Teneo is a decentralized network of autonomous AI agents that unlock real-time public data from social media platforms and websites – rewarding users for powering the network. By running a Teneo Community Node, anyone can contribute computing power to access, verify, and distribute valuable data. With over 5 million users worldwide and 15+ million daily data transfers, Teneo is redefining how data is accessed, shared, and incentivized – fueling a smarter, fairer, and more open AI-powered future.
Angel Investor
May 2023
Chaldal.com is an online shop based in Dhaka, Bangladesh. It is a service rooted on the idea that shopping for necessities should not be a burden. At Chaldal, we believe that time is valuable to our fellow Dhaka residents, and that they should not have to waste hours in traffic, brave the weather and wait in line just to buy some eggs – which is why we deliver everything you need right at your door-step and at no additional cost! Chaldal is a work in progress, and we hope to get better over time. We are firm believers in using technology to improve Bangladesh, and we will continue to invest all our effort in pushing the boundaries of technology in this country.
late stageRetail
Angel Investor (Exit)
Dec 2022
Biome Diagnostics GmbH (BiomeDx®) is an Austrian based MedTech company committed to advance precision medicine by pioneering microbiome-based technologies that transform cancer care. The company is strategically positioned at the intersection of state-of-the-art DNA sequencing and advanced machine learning algorithms to develop first in class technologies for routine clinical practice. Additionally to the lifestyle product myBioma (www.mybioma.com) for end-customers, the company focuses on the development of medically certified products in the area of gut microbiome and cancer. As safety and health of patients are top priorities, the company has already been repeatedly certified according to ISO 9001 (quality management systems) and ISO 13485 (medical devices). BiomeDx® is worldwide the first microbiome company double ISO-certified.
Angel Investor
Nov 2022
ELOOP is an e-carsharing service from Vienna. With silent and emission-free vehicles, the start-up wants to improve the quality of life in the city and drive positive change in urban mobility. With the company’s own ELOOP ONE Token, the sharing approach is taken even further and enables everyone to participate in the trip revenues. Further information at www.eloop.app/en Beyond its own operations, ELOOP also empowers other companies by providing cutting-edge tokenization software, fostering seamless integration with Web3 networks. By connecting diverse industries such as mobility and energy, ELOOP paves the way for revolutionary collaborations and unlocks new possibilities for the transformation of the economy with the ELOOP Network. Let’s drive change together!
Angel Investor
Nov 2022
SAIZ Recommender & SAIZ Studio: our AI and data-driven softwares, providing size recommendation for users, optimizing design with customer analytics and reducing e-commerce returns rates by aligning body and garment data. This holistic approach has allowed us to address the industrys core challenges, from operational efficiency to sustainability. The result? Optimized products, reduced returns, increased conversions, and a redefined shopping experience. Dive into the future of fit-tech with SAIZ, and join us in reshaping the fashion landscape, one perfect fit at a time.
Angel Investor
Oct 2022
Bumpa is the best business management app for SMEs in Africa. 

 With the Bumpa app, business owners can: - Create a business website. - Display products & receive payment - Record sales - Issue invoices/receipts - Receive financial reports -Manage orders.
Angel Investor
Jul 2022
QuickSpeech ist die intelligente Microlearning-Plattform, die automatisch zum täglichen Training motiviert. Die Plattform trainiert durch smartes Microlearning eigenes Personal oder Vertriebspartner in kurzen Wissensportionen spielerisch. Nutzer spielen in Gruppen, erreichen Punkte und können Belohnungen verdienen. Die Vorteile von QuickSpeech auf einen Blick: 🤝 Täglicher Trainings-Kontakt zu allen, die die Produkte verkaufen 😲 Kontakt zur Prime Time der Aufmerksamkeit 🧠 Check, ob Leute Inhalte auch wirklich verstanden haben (& was nicht) 💬 Feedback, was Kunden/MA draußen direkt brauchen 🌱Komplett individualisierbar 🌱Einzigartiger Content-Creation-Service 🌱Nachhaltiger Erfolg Wir bieten frei gestaltbare Bereiche und vergewissern, dass unsere Methode langfristige Erfolge erzielt. Erfolgreiche Einsatzbereiche 🔹Vertrieb (intern + über Partner) 🔹Mitarbeiter ohne Schreibtisch (Handel, Außendienst, Wartung, ...) 🔹Kundenschulungen 🔹Franchise 🔹Unterweisungen 🔹Lehrlinge 🔹Onboarding QuickSpeech ist die Plattform, die Ihren Umsatz durch spielerisches Training nachhaltig steigert. lukas.snizek@quickspeech.net +43 660 277 84 10
mid stageE-learning
Angel Investor
May 2022
Our mission: to give patients back more of their own skin to make them well again. CUTISS is a Swiss clinical-stage life sciences company focussed on regenerative medicine, skin tissue engineering, and skin pigmentation. We are developing the first personalized and automated skin tissue therapy offering life-saving and life-changing medical treatments for patients with severe skin injuries. Our lead product denovoSkin promises to take skin surgery to the next level and revolutionize current treatments. It is a bio-engineered and personalized dermo-epidermal human skin graft, currently in Phase 2 clinical trials in Switzerland and the European Union. It has Orphan Drug Designation for the treatment of burns from Swissmedic, EMA, and FDA. CUTISS is also developing the world’s first machine that can automate the entire production process of the personalised skin graft. Our company’s knowledge in skin bio-engineering and biology offers other growth opportunities in regenerative medicine, and also beyond the medical domain. Established in 2017, CUTISS is a spin-off from University of Zurich (UZH) / University Children’s Hospital. We successfully exited the Wyss Zurich accelerator in 2022. Headquartered at the Bio-Technopark in Zurich, CUTISS won the Top 100 Swiss Startup Award 2020, and has raised over CHF 55 million from private investors, family offices and public bodies.
Angel Investor
Apr 2022
DeepZen turns your text into audio content that’s rich with the emotion, intonation and rhythm of the natural voice by using AI. We produce digital voice solutions for audiobooks, advertising, marketing, brand voices and other types of voice content, including podcasting, gaming and virtual assistants.
Angel Investor
Apr 2022
Advanced Malware Analysis Solutions
Angel Investor
Mar 2022
Monkee has the mission, to help millions of people to achieve their (financial) goals and dreams without building up debt. Monkee helps you to save more money for whats important to you. With the FutureBoost we offer you a completely new alternative to interest rates to let your savings grow: With every purchase at one of our partners you receive financial contributions to your saving goals. Like Cashback, just much better. With our "Save Now Buy Later" approach we aim to offer a responsible alternative to consumer credits and "Buy Now Pay Later".
Angel Investor
Oct 2020
Midnightdeal is an innovative hotel marketplace for travellers looking for premium hotel deals. We allow travellers to name their own price, and hotels can accept these, depending on their occupancy. By using our system, hotels can boost their revenue, without having to publicly lower their prices. After a successful market launch in 2018, Midnightdeal is currently selling dream vacations all over the DACH-region, with plans to expand to further European markets in 2021.
Angel Investor
Aug 2020
Artivive brings art to life. We are Artivive, a Viennese start-up founded in 2017 aiming to change how art is made and consumed. We offer an easy to use augmented reality tool for artists to create, museums to expand and galleries to impress. With Artivive a real artwork can be extended by a digital layer to create a unique experience. We are the real connection between classic and digital art. We offer a free application, Artivive, available on Google Play and Apple App Store and a content management system, called Bridge, that links two worlds. Email: hello@artivive.com
Experience · 16 entries
All (16)
Investments (14)
2024
Partner
Jul 2024
Nest Invest provides top-notch project sales and marketing management services, alongside efficient investment consulting and HR management solutions. Nest Invest crafts profitable solutions tailored for agents, developers, and investors by its skilled workforce, cutting-edge technology and effective data-driven strategies, all meticulously aligned with specific business objectives. Notably, Nest Invest’s mission transcends borders, encompassing both domestic and foreign markets. Since 2019, Nest Invest has demonstrated remarkable process in reaching diverse domestic and international client network. During this period, Nest Invest is dedicated to removing obstacles faced by the sales force, ensuring that each project attains the value it rightfully deserves.
mid stageReal Estate
Angel Investor
May 2024
We believe that buying, selling, or investing in real estate seriously matters at any point in life. In this sense, we strive to provide the greatest opportunities possible to real estate professionals, who are present at each of these stages. To accomplish our vision we dedicated ourselves to bringing all of the world’s fragmented real estate data together in one place, enriching it with advanced analytics technologies to serve with the simplicity of our products.
Angel Investor
Apr 2024
Teneo is a decentralized network of autonomous AI agents that unlock real-time public data from social media platforms and websites – rewarding users for powering the network. By running a Teneo Community Node, anyone can contribute computing power to access, verify, and distribute valuable data. With over 5 million users worldwide and 15+ million daily data transfers, Teneo is redefining how data is accessed, shared, and incentivized – fueling a smarter, fairer, and more open AI-powered future.
2023
Angel Investor
May 2023
Chaldal.com is an online shop based in Dhaka, Bangladesh. It is a service rooted on the idea that shopping for necessities should not be a burden. At Chaldal, we believe that time is valuable to our fellow Dhaka residents, and that they should not have to waste hours in traffic, brave the weather and wait in line just to buy some eggs – which is why we deliver everything you need right at your door-step and at no additional cost! Chaldal is a work in progress, and we hope to get better over time. We are firm believers in using technology to improve Bangladesh, and we will continue to invest all our effort in pushing the boundaries of technology in this country.
late stageRetail
2022
Angel Investor (Exit)
Dec 2022
Biome Diagnostics GmbH (BiomeDx®) is an Austrian based MedTech company committed to advance precision medicine by pioneering microbiome-based technologies that transform cancer care. The company is strategically positioned at the intersection of state-of-the-art DNA sequencing and advanced machine learning algorithms to develop first in class technologies for routine clinical practice. Additionally to the lifestyle product myBioma (www.mybioma.com) for end-customers, the company focuses on the development of medically certified products in the area of gut microbiome and cancer. As safety and health of patients are top priorities, the company has already been repeatedly certified according to ISO 9001 (quality management systems) and ISO 13485 (medical devices). BiomeDx® is worldwide the first microbiome company double ISO-certified.
Show all 16 entries ↓
Investment activity
2020–2024 · 14 investments
20202202292023120242
Recent (last 2 years)Earlier